Last updated: July 10, 2023
Sponsor: Asif Ali
Overall Status: Active - Recruiting
Phase
N/A
Condition
Metabolic Syndrome
Metabolic Disorders
Diabetes Prevention
Treatment
Pomegranate seed powder
Clinical Study ID
NCT05944029
UVAS
Ages 30-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- BMI > 25kg/m2
- Dyslipidemia
- Altered blood glucose level
- Age 30-55 ( male and female)
Exclusion
Exclusion Criteria:
- Thyroid disorder
- Liver disease
- Kidney disorder
- Cancer etc
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Pomegranate seed powder
Phase:
Study Start date:
February 20, 2023
Estimated Completion Date:
August 24, 2023
Study Description
Connect with a study center
University of Veterinary and Animal sciences Lahore
Lahore, Punjab 54000
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.